# FDA Inspection 867536 - WSM Investments LLC dba Topco Sales - February 12, 2014

Source: https://www.keypedia.com/records/fda_inspections/wsm-investments-llc-dba-topco-sales/158d3e5b-10c3-4c8c-b492-3ee2de34d370
Source feed: FDA_Inspections

> FDA Inspection 867536 for WSM Investments LLC dba Topco Sales on February 12, 2014. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 867536
- Company Name: WSM Investments LLC dba Topco Sales
- Inspection Date: 2014-02-12
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 867536 - 2014-02-12](https://www.keypedia.com/records/fda_inspections/wsm-investments-llc-dba-topco-sales/d32497ff-fd9d-413d-8100-56626a206296)
- [FDA Inspection 735353 - 2011-07-19](https://www.keypedia.com/records/fda_inspections/wsm-investments-llc-dba-topco-sales/720305c2-d19c-406f-bbd3-837554f2fce1)
- [FDA Inspection 657997 - 2010-04-20](https://www.keypedia.com/records/fda_inspections/wsm-investments-llc-dba-topco-sales/79cd37bc-e6df-440e-a92d-1d8811f476c3)

Company: https://www.keypedia.com/companies/wsm-investments-llc-dba-topco-sales/35bc6810-e6e8-48f2-952a-f669109a2e34

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c